Bacterial Conjunctivitis drugs in development, 2023

GlobalData tracks 6 drugs in development for Bacterial Conjunctivitis by six companies/universities/institutes. The top development phase for Bacterial Conjunctivitis is preclinical, with three drugs in that stage.

Insights into bacterial coexistence in fungal cells

An organism as a tenant in another – in biology, this often works quite well. ETH researchers have now shed light on how such a

October 3, 2024

Study: Many older adults worry about costs, time off work and COVID-19 risk when considering surgery

When it comes to having surgery, older adults don’t just base their decision on how much pain they’ll feel and how quickly they’ll recover, a

January 31, 2024

Beta-blockers show no benefit for heart attack patients with normal heart function

The REDUCE-AMI trial found that long-term beta-blocker therapy does not reduce mortality risk in acute myocardial infarction patients with preserved left ventricular ejection fraction compared

April 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.